Rob Catlin Email & Phone Number

Newport Beach, California, US

Established consulting practice for medical aesthetic and dermatology companies. Clients include companies operating in areas of energy-based medical devices, facial injectables (i.e. dermal fillers), online/digital skincare, and professional channel skincare.

Malvern, PA, US

• Led quickly growing new business line and pivoted during critical external events to continue implementing the strategic business plan, even as it evolved through major external factors. Was instrumental in launching.
• Reworked launch activities and reformulated sales plans to meet the changed forecasts due to COVID-19 supply chain delays.
• Launched QWO in March 2021 with an “Early Experience Program” (EEP) involving 300 HCPs, followed by outside EEP customers in April. Met and exceeded every internal financial forecast for the product in 2021.
• Updated messaging and began a clinical development program to address the issue of discoloration that emerged in Q4 2021. Recognized with the 2021 Medical Affairs “Excellence in Cross-Functional Partnership” Award.
• Fostered a divisional culture that was regarded continuously by stakeholders as the best in the company, leading to the highest engagement results despite complex environmental factors and outside influences.
• Guided Endo Aesthetics through unprecedented disruption caused by three major events: unforeseen adverse event with QWO (skin discoloration not observed in any clinical trials), Endo’s unexpected loss of exclusivity of.

Malvern, PA, US

• Hand-picked as the first employee to create a new company and division to support the launch of a collagenase-based injectable to treat cellulite (named QWO), the first FDA-approved injectable product to treat cellulite.
• Developed messaging and positioning of EA and QWO as bringing significant innovation to an unmet need; developed a non-branded campaign to help create cellulite awareness and foundation for a new category of cellulite.
• Hired and developed a team of >100 from scratch comprising marketers, professional relations executives, executive director of sales, area directors/managers, field/inside sales representatives, account directors, and.
• Engaged personal network of key opinion leaders in plastic surgery, dermatology, and the medical spa channel to introduce and credential Endo as a new entrant to medical aesthetics, highlighted Endo’s significant track.
• Helped create positioning and messaging with investors, earnings call scripts and Q&A.

• Developed and led commercial strategy for photomedicine-based medical devices for therapeutic and aesthetic applications.
• Led corporate development activities, including identifying strategic alliances, company fundraising, developing corporate key opinion leader physician advisory board, and developing new products.
• Created all product branding, positioning, messaging, and pricing for Revian Red (Low-level light therapy hair-growing device).

Spearheaded a team of 10 marketers focusing on optimizing consumer engagement for the complete portfolio of Merz aesthetic products across DTC channels, including digital, social media, PR, and celebrity influencers. Oversaw HCP program (My Merz Select).

• Led global HCP marketing for Ultherapy System, created and managed inside sales organization in 2014 for Ulthera, Inc., and oversaw the launch of the Cellfina System in both the US and OUS in 2015.
• Redesigned and updated KOL and HCP marketing strategies in US and OUS for the Ultherapy System lead generation as well as created and managed a new inside sales organization at Ulthera; both generated >$X.XM (~XX% of.
• Helped Ulthera get acquired by Merz Aesthetics for $600M in 2015 and played a key leadership role in transition/integration.
• Developed and executed Cellfina commercial strategy for a new minimally invasive cellulite medical device for the US and OUS.
• Provided direction, oversight, and approval placement for capital sales team with the first XXX Cellfina Systems in the US market.
• Led the official launch of Cellfina in December 2015 and recognized $XXM in revenue in 12 months – category leader in Class II medical devices (category size = $53M).

Scottsdale, AZ, US

• Developed and managed $140M P&L for the Restylane® family of products and product life cycle activities for the Restylane and Emervel® family of products. Directed all professional and consumer marketing strategies for.
• Identified growth opportunities to expand reach with customer base and product portfolio utilization with existing and new accounts. Developed and implemented a new physician loyalty platform (Medicis/Mentor Valued.

Scottsdale, AZ, US

• Managed a $30M aesthetic facial injectable portfolio (Dysport and Restylane) for the largest region in the US.
• Delivered 20% facial filler growth in 2012 vs. 2011 (highest YOY growth in the US).-2011 Regional Manager of the Year-2011 Region of the Year-2011 Circle of Excellence award winner

Dublin, Coolock, IE

• Managed BOTOX Cosmetic HCP and physician loyalty programs; Created Natrelle consumer CRM program, “MyNatrelle,” and managed plastic surgeon loyalty programs.
• Developed Allergan’s multimillion-dollar HCP loyalty program, Allergan Partner Privileges (APP), that stands today as the industry’s gold standard program for all of Allergan’s aesthetic products; Won "Certificate of.

Mba, Finance And Marketing

B.S., Finance, Marketing